|
|
Thursday, December 8, 2005
Celladon Raises $30M
La Jolla-based Celladon has raised a $30M round of Series B funding. The company said that it will use the funding to complete testing and advance its product for heart failure. Funding came from Kleiner Perkins Caufield & Byers and Domain Associates, with participation from existing investors Enterprise Partners Venture Capital and Venrock Associates. Celladon is developing treatments for heart failure and other cardiovascular diseases. Dr. Jesse Treu of Domain and Joseph Lacob of Kleiner have joined the company's board.
posted on Thursday, December 8, 2005 (Link to more information)
|
 RSS Feed
 Newsletter
Previous news:
Friday, August 29, 2008
Thursday, August 28, 2008
Wednesday, August 27, 2008
Tuesday, August 26, 2008
Monday, August 25, 2008
|
